177 related articles for article (PubMed ID: 12227898)
1. Progestins and uterine leiomyoma.
Schweppe KW
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
[TBL] [Abstract][Full Text] [Related]
2. Progesterone: a critical role in the pathogenesis of uterine myomas.
Rein MS; Barbieri RL; Friedman AJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):14-8. PubMed ID: 7847524
[TBL] [Abstract][Full Text] [Related]
3. Advances in uterine leiomyoma research: the progesterone hypothesis.
Rein MS
Environ Health Perspect; 2000 Oct; 108 Suppl 5():791-3. PubMed ID: 11035984
[TBL] [Abstract][Full Text] [Related]
4. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
Zeng C; Gu M; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
[TBL] [Abstract][Full Text] [Related]
5. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the inhibitory effect of gonadotropin releasing hormone (GnRH) agonist, selective estrogen receptor modulator (SERM), antiprogesterone on myoma cell proliferation in vitro.
Chung YJ; Chae B; Kwak SH; Song JY; Lee AW; Jo HH; Lew YO; Kim JH; Kim MR
Int J Med Sci; 2014; 11(3):276-81. PubMed ID: 24516352
[TBL] [Abstract][Full Text] [Related]
7. [Drug treatments for uterine fibroma: rationale].
Fernandez H; Azoulay C; Rostoker G;
J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):360-405. PubMed ID: 16136663
[No Abstract] [Full Text] [Related]
8. Current and future medical treatments for menometrorrhagia during the premenopause.
Bouchard P
Gynecol Endocrinol; 2011 Dec; 27 Suppl 1():1120-5. PubMed ID: 22182055
[TBL] [Abstract][Full Text] [Related]
9. Role of Medical Management for Uterine Leiomyomas.
Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
[TBL] [Abstract][Full Text] [Related]
10. Other medical management of uterine fibroids.
Eldar-Geva T; Healy DL
Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):269-88. PubMed ID: 10023422
[TBL] [Abstract][Full Text] [Related]
11. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
12. Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin.
Ueki M; Okamoto Y; Tsurunaga T; Seiki Y; Ueda M; Sugimoto O
J Obstet Gynaecol (Tokyo 1995); 1995 Feb; 21(1):1-7. PubMed ID: 8591104
[TBL] [Abstract][Full Text] [Related]
13. Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.
De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS
Hum Reprod; 1997 Feb; 12(2):357-60. PubMed ID: 9070725
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
15. Progesterone antagonists and progesterone receptor modulators.
Spitz IM
Expert Opin Investig Drugs; 2003 Oct; 12(10):1693-707. PubMed ID: 14519088
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
Cook JD; Walker CL
Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
[TBL] [Abstract][Full Text] [Related]
17. Etiology, symptomatology, and diagnosis of uterine myomas.
Parker WH
Fertil Steril; 2007 Apr; 87(4):725-36. PubMed ID: 17430732
[TBL] [Abstract][Full Text] [Related]
18. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?
Donnez J; Donnez O; Dolmans MM
Fertil Steril; 2014 Sep; 102(3):640-8. PubMed ID: 25106762
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
Stovall TG
Clin Obstet Gynecol; 1993 Sep; 36(3):642-9. PubMed ID: 8403610
[No Abstract] [Full Text] [Related]
20. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
